Development of an Aptamer/CRISPR-Cas12a-Based Dual-Modal Biosensor for Fusobacterium nucleatum Detection in Non-Invasive Colorectal Cancer Screening
Analytical Chemistry · 2025
DOI: 10.1021/acs.analchem.5c04132 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, 2025. Verfasst von Xinjing Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China. Hauptthemen laut MEDLINE: Fusobacterium nucleatum, Colorectal Neoplasms, Biosensing Techniques, CRISPR-Cas Systems. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Science, Technology and Innovation Commission of Shenzhen Municipality, Shenzhen University.
Abstract (Originalsprache)
Colorectal cancer (CRC) is the third most common cancer and leading cause of cancer-related deaths worldwide. However, current CRC screening methods are complex, invasive, and tend to exhibit low sensitivity. Recent evidence has highlighted gut microbiota dysbiosis, especially elevated Fusobacterium nucleatum levels, as a promising biomarker for CRC. In this study, a sensitive and specific detection platform was developed for F. nucleatum by combining a highly specific aptamer with rolling circle amplification (RCA) and the CRISPR/Cas12a technology. The aptamer enables specific target recognition, while RCA amplifies the target signal, and the Cas12a-mediated cleavage of a fluorescence-quenching substrate generates a quantifiable fluorescence or grayscale signal. Using a microplate reader, this assay achieved a limit of detection (LOD) of 3.68 CFU/mL; furthermore, by incorporating smartphone-assisted ImageJ grayscale analysis, it elevated the LOD to 4.30 CFU/mL, thereby enabling a dual-mode output along with on-site applicability. Additionally, the strong correlation between the two signals allowed for mutual validation. Upon application to clinical fecal samples, the developed method sensitively distinguished CRC patients from healthy controls, and its results correlated with the quantitative polymerase chain reaction results. This triple-synergistic platform, integrating aptamer specificity, RCA amplification, and CRISPR/Cas12a sensitivity, enables the noninvasive, ultrasensitive detection of F. nucleatum, supporting early CRC screening, prognosis monitoring, and microbiome-targeted therapy. Moreover, this approach overcomes the challenges of detecting low-abundance bacteria in early stage CRC and advances the precision of microbiome-based diagnostics for CRC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China.
- Guangdong Provincial Key Laboratory of Chinese Medicine Ingredients and Gut Microbiomics, School of Pharmacy, Shenzhen University Medical School, Shenzhen University, Shenzhen 518055, P. R. China.
- State Key Laboratory of Chemical Oncogenomics, Tsinghua Shenzhen International Graduate School, Shenzhen 518055, P. R. China.
- Institute of Biomedical Health Technology and Engineering, Shenzhen Bay Laboratory, Shenzhen 518000, P. R. China.
- Department of Gastrointestinal Surgery, Shenzhen Second People's Hospital, Shenzhen 518035, P. R. China.
ORCID-Profile: Hui Chen, Longshan Zhao, Yuyang Jiang, Yan Chen
Förderung
- Science, Technology and Innovation Commission of Shenzhen Municipality
- Shenzhen University
Zitieren
APA
Wang, X., Feng, S., Chen, H., Zhou, B., Fan, T., Qin, Y., Zhao, L., Jiang, Y., & Chen, Y. (2025). Development of an Aptamer/CRISPR-Cas12a-Based Dual-Modal Biosensor for Fusobacterium nucleatum Detection in Non-Invasive Colorectal Cancer Screening. Analytical Chemistry. https://doi.org/10.1021/acs.analchem.5c04132
Vancouver
Wang X, Feng S, Chen H, Zhou B, Fan T, Qin Y, et al. Development of an Aptamer/CRISPR-Cas12a-Based Dual-Modal Biosensor for Fusobacterium nucleatum Detection in Non-Invasive Colorectal Cancer Screening. Analytical Chemistry. 2025. doi:10.1021/acs.analchem.5c04132
BibTeX
@article{Wang2025,
author = {Wang, Xinjing and Feng, Shanshan and Chen, Hui and Zhou, Bo and Fan, Tingting and Qin, Ying and Zhao, Longshan and Jiang, Yuyang and Chen, Yan},
title = {Development of an Aptamer/CRISPR-Cas12a-Based Dual-Modal Biosensor for Fusobacterium nucleatum Detection in Non-Invasive Colorectal Cancer Screening},
journal = {Analytical Chemistry},
year = {2025},
doi = {10.1021/acs.analchem.5c04132}
}
EUVIMED